Restoration of the molecular clock is tumor suppressive in neuroblastoma
MYCN is frequently amplified in neuroblastomas. Here, the authors show that MYCN disrupts the molecular clock by downregulating clock activator RORα and that the reactivation of RORα restores BMAL1 activity, and inhibits lipid metabolism and neuroblastoma growth
Guardado en:
Autores principales: | Myrthala Moreno-Smith, Giorgio Milazzo, Ling Tao, Baharan Fekry, Bokai Zhu, Mahmoud A. Mohammad, Simone Di Giacomo, Roshan Borkar, Karthik Reddy Kami Reddy, Mario Capasso, Sanjeev A. Vasudevan, Pavel Sumazin, John Hicks, Nagireddy Putluri, Giovanni Perini, Kristin Eckel-Mahan, Thomas P. Burris, Eveline Barbieri |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/36f78ce6f76041c49c8161f0733a70f4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
XBP1 links the 12-hour clock to NAFLD and regulation of membrane fluidity and lipid homeostasis
por: Huan Meng, et al.
Publicado: (2020) -
Neuroblastoma
por: Fuentes,Luis, et al.
Publicado: (1976) -
JMJD6 is a tumorigenic factor and therapeutic target in neuroblastoma
por: Matthew Wong, et al.
Publicado: (2019) -
PARATESTICULAR INVOLVEMENT IN NEUROBLASTOMA
por: Volkan KÖSE, et al.
Publicado: (2021) -
Incompatibility of the circadian protein BMAL1 and HNF4α in hepatocellular carcinoma
por: Baharan Fekry, et al.
Publicado: (2018)